Ymab investor news: rosen, a leading and longstanding firm, encourages y-mabs therapeutics, inc. investors to secure counsel before important deadline in securities class action - ymab

New york, new york--(newsfile corp. - january 23, 2023) - why: rosen law firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of y-mabs therapeutics, inc. (nasdaq: ymab) between october 6, 2020 and october 28, 2022, both dates inclusive (the "class period"). a class action has already been filed.
YMAB Ratings Summary
YMAB Quant Ranking